Cardiovascular magnetic resonance: Applications in daily practice

Cardiology in Review

Volumn 19, Issue 5, 2011, Pages 246-254

  Jiji, Ronny S ^a   Kramer, Christopher M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

cardiomyopathies; magnetic resonance imaging; viability

Indexed keywords

CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CONGENITAL HEART DISEASE; DIAGNOSTIC VALUE; HUMAN; ISCHEMIA; MEDICAL PRACTICE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL DISEASE; REVIEW;

DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 80051708274     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e31821f4d6a     Document Type: Review

References (102)

1. ACCF/ACR/AHA/NASCI/SCMR 2010 Expert consensus document on cardiovascular magnetic resonance. J Am Coll Cardiol 2010;55:2614-2662.
2. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002. (Pubitemid 29529292)
3. Wagner A, Marholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374-379. (Pubitemid 36164969)
4. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
5. Sharma S, Raman S, Sun B, et al. Anterior wall viability and low ejection fraction predict functional improvement after CABG. J Surg Res. April 24, 2010 [epub].
6. Selvanayagam JB, Kardos A, Francis JM, et al. Value of delayedenhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation. 2004;110:1535-1541. (Pubitemid 39297973)
7. Pegg TJ, Selvanayagam JB, Jennifer J, et al. Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularization, based on late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:56.
8. Bove CM, DiMaria JM, Voros S, et al. Dobutamine response and myocardial transmurality: functional improvement after coronary artery bypass grafting-initial experience. Radiology. 2006;240:835-841. (Pubitemid 44267342)
9. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation. 2004;109:2172-2174. (Pubitemid 38625392)
10. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765-772. (Pubitemid 28135339)
11. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J. 2005;26:549-557. (Pubitemid 40461096)
12. Eitel I, Desch S, Fuernau G, et al. Prognostic significance and determinants of myocardial salvage as assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol. 2010;55:2489-2490.
13. Aletras AH, Tilak GS, Natanzon A, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation. 2006;113:1865-1870. (Pubitemid 43739398)
14. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation. 2004;109:2411-2416. (Pubitemid 38679560)
15. Berry C, Kellman P, Mancini C, et al. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging. 2010;3:527-535.
16. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparision with dobutamine stress echocardiography. Circultation. 1999;99:763-770. (Pubitemid 29083016)
17. Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29:480-489. (Pubitemid 351264187)
18. Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006;47:1630-1638.
19. Steel K, Broderick R, Gandla V, et al. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation. 2009;120:1390-1400.
20. Jahnke Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation. 2007;115:1769-1776. (Pubitemid 46648614)
21. Korosoglou G, Elhmidi Y, Steen H, et al. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1, 493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol. 2010;56:1225-1234.
22. Dall'Armellina E, Morgan TM, Mandapaka S, et al. Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. J Am Coll Cardiol. 2008;52:279-286. (Pubitemid 351957860)
23. Greenwood JP, Younger JF, Ridgway JP, et al. Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction. Heart. 2007;93:1363-1368. (Pubitemid 351480131)
24. Raman SV, Dickerson JA, Jekic M, et al. Real-time cine and myocardial perfusion with treadmill exercise stress cardiovascular magnetic resonance in patients referred for stress SPECT. J Cardiovasc Magn Reson. 2010;12:41.
25. Miller CD, Hwang W, Hoekstra JW, et al. Stress cardiac magnetic resonance imaging with observation unit care reduces cost for patients with emergent chest pain: a randomized trial. Ann Emerg Med. 2010;56:209-219.
26. Inkanisorn WP, Kwong RY, Bohme NS, et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol. 2006;47:1427-1432.
27. Maseri A, Chierchia S, Davies G. Pathophysiology of coronary occlusion in acute infarction. Circulation. 1986;73:233-239. (Pubitemid 16127398)
28. Assomull RG, Lyne JC, Niall K, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Hear J. 2007;28:1242-1249. (Pubitemid 47343853)
29. Steen H, Madadi-Schroeder M, Lehrke S, et al. Staged cardiovascular magnetic resonance for differential diagnosis of troponin T positive patients with low likelihood for acute coronary syndrome. J Cardiovasc Magn Reson. 2010;12:51.
30. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadoliniumenhanced cardiovascular magnetic resonance. Circulation. 2003;108:54-59. (Pubitemid 36859020)
31. Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008;51:2414-2421. (Pubitemid 351826874)
32. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48:1977-1985. (Pubitemid 44738448)
33. Moon JC, Fisher NG, McKenna WJ, et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart. 2004;90:645-649. (Pubitemid 38668538)
34. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005;112:855-861. (Pubitemid 41170072)
35. Maron MS, Maron BJ, Harrigan C, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54:220-228.
36. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. J Amer Coll Cardiol 2003;42:1687-1713.
37. Moon J C C, Sachdev B, Elkington AG, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease: evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J. 2003;24:2151-2155. (Pubitemid 37486535)
38. Selcuk Adabag A, Maron BJ, Appelbaum E, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascaular magnetic resonance. J Am Coll Cardiol. 2008;51:1369-1374. (Pubitemid 351443083)
39. Rubenstein R, Glockner JF, Ommen SR, et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail. 2010;3:51-58.
40. Bruder O, Wagner A, Jensen CJ, et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;56:875-887.
41. Salerno M, Kramer CM. Prognosis in hypertrophic cardiomyopathy with contrast-enhanced cardiac magnetic resonance: the future looks bright. J Am Coll Cardiol. 2010;56:888-889.
42. Tandri H, Castillo E, Ferrari VA, et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol. 2006;48:2277-2284. (Pubitemid 44855415)
43. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121:1533-1541.
44. Tandri H, Macedo R, Calkins H, et al. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the north american arrhythmogenic right ventricular dysplasia (arvd/c) study. Am Heart J. 2008;155:147-153. (Pubitemid 350234765)
45. Maceira AM, Joshi H, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186-193. (Pubitemid 40139730)
46. Syed IS, Glockner JF, Feng D, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. J Am Coll Cardiol Img 2010;3:155-164.
47. Rosales Uvera SG: Cardiac Damage by Scleroderma [SCMR Website]. Available at: http://www.scmr.org/caseoftheweek/2009/09-14-CMR-in-SSc.html. Accessed February 26th, 2011.
48. Karamitsos TD, Francis JM, Myerson S, et al. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 2009;54:1407-1424.
49. Steen HS, Merten C, Refle S, et al. Prevalence of different gadolinium enhancement patterns in patients after heart transplantation. J Am Coll Cardiol. 2008;52:1160-1167.
50. Mekinian A, Lions C, Leleu X, et al. Prognosis assessment of cardiac involvement of systemic AL amyloidosis by magnetic resonance imaging. Am J Med. 2010;123:864-868.
51. Maciera AM, Prasad SK, Hawkins PN, et al. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson. 2008;10:54.
52. Bonkovsky HL, Rubin RB, Cable EE, et al. Hepatic iron concentration: non-invasive estimation by means of MR imaging techniques. Radiology. 1999;212:227.
53. Alustiza JM, Artetxe J, Castiella A, et al. MR quantification of hepatic iron concentration. Radiology. 2004;230:479-484. (Pubitemid 38133810)
54. *) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171-2179. (Pubitemid 33139463)
55. * cardiovascular magnetic resonance techniquie for diagnosis of myocardial iron overload. J Magn Reson Imaging. 2003;18:33-39. (Pubitemid 36791266)
56. * cardiovascular magnetic resonance. BJH. 2004;127:348-355. (Pubitemid 39468951)
57. Tanner MA, Galanello MD, Dessi C, et al. A randomized, placebo-controlled double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation. 2007;115:1876-1884. (Pubitemid 46598901)
58. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58:1204-1211. (Pubitemid 9092005)
59. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999;138:299-302. (Pubitemid 29379681)
60. Smedema J, Snoep G, van Kroonenburgh M, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45:1683-1690. (Pubitemid 40704507)
61. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969-1977.
62. Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow up study. Chest. 2002;122:1895-1901. (Pubitemid 36051121)
63. Chin TK, Perloff JK, Williams RG, et al. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation. 1990;82:507-513. (Pubitemid 20257829)
64. Thyny F, Jacquier A, Jop B, et al. Assessment of left ventricular noncompaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography. Arch Cardiovasc Dis. 2010;103:150-159.
65. Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular noncompaction. Insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;46:101-105. (Pubitemid 40905136)
66. Jenni R, Oechslin E, Attenhofer C, et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001;86:666-671. (Pubitemid 33086886)
67. Jacquier A, Thuny F, Bertrand H, et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J. 2010;31:1098-1104.
68. Zagrosek A, Abdel-Aty H, Boyé P, et al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. J Am Coll Cardiol Img. 2009;2:131-138.
69. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009;53:1475-1487.
70. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109:1250-1258. (Pubitemid 38379570)
71. Wagner A, Schulz-Menger J, Dietz R, et al. Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging. MAGMA. 2003;16:17-20. (Pubitemid 38325344)
72. Giorgi B, Mollet NR, Dymarkowski S, et al. Clinically suspected constrictive pericarditis: MR imaging assessment of ventricular septal motion and configuration in patients and healthy subjects. Radiology. 2003;228:417-424. (Pubitemid 36910081)
73. Kojima S, Yamada N, Goto Y. Diagnosis of constrictive pericarditis by tagged cine magnetic resonance imaging. N Engl J Med. 1999;341:373-374. (Pubitemid 29350314)
74. Lonborg J, Mathur M, Grieve SM, et al. Constrictive pericarditis diagnosed by cardiac magnetic resonance. J Am Coll Cardiol. 2010;56:e39.
75. Cheng H, Zhao S, Jiang S, et al. The relative atrial volume ratio and late gadolinium enhancement provide additive information to differentiate constrictive pericarditis from restrictive cardiomyopathy. J Cardiovasc Magn Reson. 2011;13:15.
76. Koos R, Schröder J, Kühl HP. Acute viral pericarditis without typical electrocardiographic changes assessed by cardiac magnetic resonance imaging. Eur Heart J. 2009;30:2844.
77. Chassaing S, Bensouda C, Bar O, et al. A case of partial congenital absence of pericardium revealed by MRI. Circ Cardiovasc Imaging. 2010;3:632-634.
78. Glancy DL, Roberts WC. The heart in malignant melanoma. A study of 70 autopsy cases. Am J Cardiol. 1968;21:555-571.
79. Young JM, Goldman IR. Tumor metastasis to the heart. Circulation. 1954;9:220-229.
80. Weinsaft JW, Kim RJ, Ross M, et al. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. J Am Coll Cardiol Img. 2009;2:969-979.
81. Barkhausen J, Hunold P, Eggebrecht H, et al. Detection and characterization of intracardiac thrombi on MR imaging. AJR. 2002;179:1539-1544. (Pubitemid 35386657)
82. Mollet NR, Dymarkowski S, Volders W, et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation. 2002;106:2873-2876. (Pubitemid 35424733)
83. Paydarfar D, Krieger D, Dib N, et al. In vivo magnetic resonance imaging and surgical histopathology of intracardiac masses: distinct features of subacute thrombi. Cardiology. 2001;95:40-47. (Pubitemid 32506960)
84. Srichai MB, Junor C, Rodriguez LL, et al. Clinical, imaging, and pathologic characteristics of left ventricular thrombus: a comparison of contrast enhanced magnetic resonance imaging, transthoracic echocardiography and transesophageal echocardiography with surgical or pathological validation. Am Heart J. 2006;152:75-84. (Pubitemid 43974727)
85. Weinsaft JW, Kim HW, Shah DJ, et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance. Prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol. 2008;52:148-157. (Pubitemid 351885445)
86. Gelfand EV, Hughes S, Hauser TH, et al. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson. 2006;8:503-507.
87. Djavidani B, Debl K, Lenhart M, et al. Planimetry of mitral valve stenosis by magnetic resonance imaging. J Am Coll Cardiol. 2005;45:2048-2053. (Pubitemid 40814130)
88. Caruthers SD, Lin SJ, Brown P, et al. Practical values of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography. Circulation. 2003;108:2236-2243. (Pubitemid 37363041)
89. Anselmino M, Blandino A, Beninati S, et al. Morphologic analysis of left atrial anatomy by magnetic resonance angjography in patients with atrial fibrillation: a large single center experience. J Cardiovasc Electrophysiol. 2011;22:1-7.
90. Caponi D, Corleto A, Scaglione M, et al. Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome? A randomized comparision of Carto-Merge vs. Carto-XP three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation. Europace. 2010;12:1098-1104.
91. Bertaglia E, Della Bella P, Tondo C, et al. Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CartoMergeTM Italian registry. Europace. 2009;11:1004-1010.
92. Jahnke C, Fischer J, Mirelis JG, et al. Cardiovascular magnetic resonance imaging for accurate sizing of the left atrium: predictability of pulmonary vein isolation success in patients with atrial fibrillation. J Magn Reson Imaging. 2011;33:455-463.
93. Akoum N, Daccarett M, McGann C, et al. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol. 2011;22:16-22.
94. Daccarett M, Badger TJ, Akoum N, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011;57:831-838.
95. Chung ES, Leon AR, Tavazzi L, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117:2608-2616.
96. Bilchick KC, Dimaano V, Wu KC, et al. Magnetic resonance imaging analysis of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2008;1:561-568.
97. Dave HH, Buechel ER, Dodge-Khatani A, et al. Early insertion of a pulmonary valve for chronic regurgitation helps restoration of ventricular dimensions. Ann Thorac Surg. 2005;80:1615-1621. (Pubitemid 41464271)
98. Oosterhof T, van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetrallogy of fallot using cardiovascular magnetic resonance. Circulation. 2007;116:545-551. (Pubitemid 47450263)
99. McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short-and mediumterm outcomes after transcatheter pulmonary valve placement in the expanded pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation. 2010;122:507-516.
100. Therrien J, Thorne SA, Wright A, et al. Repaired coarctation: a "costeffective" approach to identify complications in adults. J Am Coll Cardiol. 2000;35:997-1002. (Pubitemid 30189934)
101. Puranika R, Tsanga VT, Puranikb S, et al. Late magnetic resonance surveillance of repaired coarctation of the aorta. Eur J Cardiothorac Surg. 2009;36:91-95.
102. Quenot J, Boichot C, Petit A, et al. Usefulness of MRI in the follow-up of patients with repaired aortic coarctation and bicuspid aortic valve. Int J Cardiol. 2005;105:312-316. (Pubitemid 41132601)